AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Up 30.2% in September

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 89,700 shares, an increase of 30.2% from the September 15th total of 68,900 shares. Based on an average trading volume of 29,600 shares, the short-interest ratio is currently 3.0 days. Approximately 2.5% of the company’s stock are sold short.

AquaBounty Technologies Stock Performance

AQB opened at $1.13 on Friday. The company has a market capitalization of $4.37 million, a price-to-earnings ratio of -0.06 and a beta of 1.15. The business’s 50-day moving average price is $1.13 and its two-hundred day moving average price is $1.56. AquaBounty Technologies has a 1 year low of $0.81 and a 1 year high of $4.68. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.96 and a quick ratio of 1.96.

AquaBounty Technologies (NASDAQ:AQB) last announced its earnings results on Tuesday, August 6th. The company reported ($1.56) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.93) by ($0.63). The firm had revenue of $0.18 million during the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative net margin of 3,923.57% and a negative return on equity of 17.81%. Equities analysts expect that AquaBounty Technologies will post -4.86 EPS for the current fiscal year.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.